Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2022 ∙ Ren, X. Hao, Y. Wu, B. Jia, X. Niu, M. Wang, K. Li, Z.
Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis
South-East Asia Western Pacific Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Xia, Y. Zhang, X. Zhang, L. Fu, C.
Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis
Adults Older adults Herpes zoster Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Li, Z. Liu, S. Li, F. Li, Y. Li, Y. Peng, P. Li, S. He, L. Liu, T.
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ Jansen, M. H. Rondaan, C. Legger, G. Minden, K. Uziel, Y. Toplak, N. Maritsi, D. van den Berg, M. Berbers, G. Bruijning, P. Egert, Y. Normand, C. Bijl, M. Foster, H. Kone-Paut, I. Wouters, C. Ravelli, A. Elkayam, O. Wulffraat, N. M. Heijstek, M. W.
Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations
Newborn Children Adolescents Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ Lenzing, E. Rezahosseini, O. Burgdorf, S. K. Nielsen, S. D. Harboe, Z. B.
Efficacy, immunogenicity, and evidence for best-timing of pneumococcal vaccination in splenectomized adults: a systematic review
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Oh, S. Purja, S. Shin, H. Kim, M. S. Park, S. Kronbichler, A. Smith, L. Eisenhut, M. Shin, J. I. Kim, E.
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Randomized Control Trials in the Pre-Delta Era: A Systematic Review and Network Meta-Analysis
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2022 ∙ Parker, E. P. K. Desai, S. Marti, M. O'Brien, K. L. Kaslow, D. C. Kochhar, S. Olayinka, F. Cravioto, A. Nohynek, H. Hombach, J. Wilder-Smith, A.
Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
All age groups COVID-19 Safety Efficacy/effectiveness Administration
Rating:
Critically low
2022 ∙ Gualano, M. R. Santoro, P. E. Borrelli, I. Rossi, M. F. Amantea, C. Tumminello, A. Daniele, A. Beccia, F. Moscato, U.
Employee Participation in Workplace Vaccination Campaigns: A Systematic Review and Meta-Analysis
All age groups Healthcare workers Coverage
Rating:
Not applicable
2022 ∙ Tian, W. Ren, X. Han, M. Zhang, Y. Gao, X. Chen, Z. Zhang, W.
Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ McMenamin, M. E. Bond, H. S. Sullivan, S. G. Cowling, B. J.
Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology
All age groups Influenza Efficacy/effectiveness Administration
Rating:
Not applicable
Loading...